Cargando…

Can the dexamethasone intravitreal implant Ozurdex be safely administered in an out-of-operating room setting?

PURPOSE: To describe a standardized protocol of the dexamethasone intravitreal (DEX) implant Ozurdex (Allergan, Dublin, Ireland) performed in a controlled environment surgical cabin (CESC). METHODS: Retrospective and observational study conducted on patients who underwent a DEX implant between May 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cidad-Betegón, María del Pino, Armadá-Maresca, Félix, Amorena-Santesteban, Gloria, Coca-Robinot, Javier, D'Anna-Mardero, Oriana, de la Rosa-Pérez, Irene, Manzano-Muñoz, Beatriz, García-Martínez, Jesús, Asencio-Durán, Mónica, Casado-Abad, Gema
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Ophthalmology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170356/ https://www.ncbi.nlm.nih.gov/pubmed/32341839 http://dx.doi.org/10.1080/21556660.2020.1742723

Ejemplares similares

Intravitreal Dexamethasone Implant (Ozurdex) in Coats’ Disease
por: Saatci, Ali Osman, et al.
Publicado: (2013)

Fractured dexamethasone implant (OZURDEX®) following intravitreal injection
por: Aljohani, Saud M., et al.
Publicado: (2021)

A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)
por: Eris, Erdem, et al.
Publicado: (2017)

Management of Accidental Intravitreal Dexamethasone Injection Into the Lens: A Case Report
por: Siotto Pintor, Emanuele, et al.
Publicado: (2023)

Comparison of Two Anesthetic Methods for Intravitreal Ozurdex Injection
por: Karabaş, V. Levent, et al.
Publicado: (2015)

Intravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis Pigmentosa
por: Örnek, Nurgül, et al.
Publicado: (2016)

Modified insertion technique for a sustained-release dexamethasone intravitreal implant (Ozurdex®)
por: Lee, Daniel H., et al.
Publicado: (2020)

Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex(®) Outcomes
por: Udaondo, Patricia, et al.
Publicado: (2021)

Intravitreal Injection-Induced Migraine Headaches
por: Lerebours, Valerie C, et al.
Publicado: (2016)

Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema
por: Pacella, Elena, et al.
Publicado: (2013)

Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment
por: Garweg, Justus G., et al.
Publicado: (2016)

Acute Retinal Necrosis in an Immunocompetent Patient Treated With Intravitreal Ganciclovir
por: Nashawi, Mouhamed, et al.
Publicado: (2021)

Endophthalmitis After Intravitreal Bevacizumab (Avastin) Injections: An Outbreak Investigated
por: Shoaib, Khawaja K, et al.
Publicado: (2023)

Comparison of intravitreal dexamethasone implant and anti-VEGF drugs in the treatment of retinal vein occlusion-induced oedema: a meta-analysis and systematic review
por: Ming, Shuai, et al.
Publicado: (2020)

Adult Coats’ Disease Successfully Managed with the Dexamethasone Intravitreal Implant (Ozurdex®) Combined with Retinal Photocoagulation
por: Martínez-Castillo, Sebastián, et al.
Publicado: (2012)

Use of an Intravitreal Dexamethasone Implant (Ozurdex) in a Case with Accidental Foveal Photocoagulation by Alexandrite Laser
por: Bulut, Muhammed Nurullah, et al.
Publicado: (2016)

Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
por: Castro-Navarro, Verónica, et al.
Publicado: (2019)

The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review
por: Poku, Edith, et al.
Publicado: (2014)

Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2
por: Gonzalez Martinez, Orlando G, et al.
Publicado: (2023)

A surprising intravitreal injection attempt: Ozurdex™ implantation for Behçet's disease
por: Furundaoturan, Onur, et al.
Publicado: (2020)

Submacular Hemorrhage Following Aflibercept Intravitreal Injection: A Report of Two Cases
por: Khoo, Chloe, et al.
Publicado: (2022)

The Risk of Non-arteritic Ischemic Optic Neuropathy Post-intravitreal Bevacizumab Injection
por: Fugara, Nasser A, et al.
Publicado: (2022)

Immediate Rise in Intraocular Pressure After First-Time Intravitreal Injection of Bevacizumab
por: Mahar, Pir S, et al.
Publicado: (2023)

Effect of Intravitreal Brolucizumab in the Treatment of Polypoidal Choroidal Vasculopathy With Foveal Lipid Exudation
por: Carta, Valentina, et al.
Publicado: (2023)

Subretinal Neovascular Membrane in Wet Age-Related Macular Degeneration Managed With Intravitreal Ranibizumab
por: Sharma, Tanishq S, et al.
Publicado: (2021)

Acceptability of intravitreal injections in geographic atrophy: protocol for a mixed-methods pilot study
por: Enoch, Jamie, et al.
Publicado: (2021)

Staphylococcus lugdunensis Endophthalmitis Following Intravitreal Anti-vascular Endothelial Growth Factor Injections
por: Ahmed, Umar, et al.
Publicado: (2022)

Adjuvant Intravitreal Bevacizumab for Retinal Neovascularization in Eales’ Disease Associated With Latent Mycobacterium Tuberculosis
por: Gonzalez Martinez, Orlando G, et al.
Publicado: (2023)

Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)
por: Loutfi, Mohamed, et al.
Publicado: (2014)

Dexamethasone Intravitreal Implant (Ozurdex) for Long-Term Macular Edema after Epiretinal Membrane Peeling Surgery
por: Chang, Yo-Chen, et al.
Publicado: (2018)

Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema
por: Furino, Claudio, et al.
Publicado: (2017)

Ozurdex (dexamethasone intravitreal implant) for the treatment of intermediate, posterior, and panuveitis: a systematic review of the current evidence
por: Saincher, Saanwalshah Samir, et al.
Publicado: (2020)

Incidence of Acute Endophthalmitis After Intravitreal Bevacizumab Injection at a Tertiary Care Hospital in Lahore
por: Ahmed, Nasir, et al.
Publicado: (2021)

Full-Thickness Macular Hole After Intravitreal Conbercept Injection in Branch Retinal Vein Occlusion
por: Xie, Pinxue, et al.
Publicado: (2023)

Reduction in choroidal thickness of macular area in polypoidal choroidal vasculopathy patients after intravitreal ranibizumab therapy
por: Nishide, Tadayuki, et al.
Publicado: (2013)

Outcomes of Group D Retinoblastoma With Resistant Vitreous Seeds After Integration of Intravitreal Chemotherapy to the Treatment Protocol
por: Amin, Saima, et al.
Publicado: (2020)

Use of Intravitreal Methotrexate Infusion in Complicated Retinal Detachment for Prevention of Proliferative Vitreoretinopathy in a Pilot Study
por: Jahangir, Sana, et al.
Publicado: (2021)

Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners
por: Yiallouridou, Christina, et al.
Publicado: (2023)

Hypotony Following Intravitreal Silicone Oil Removal in a Patient With a Complex Retinal Detachment With Giant Retinal Tear
por: Gkizis, Ilias, et al.
Publicado: (2021)

Secondary glaucoma after intravitreal dexamethasone implant (Ozurdex) injection in patients with retinal disorder: A retrospective study
por: Sweta, VD, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_siglat7t8bc5vtdjo5dpqd7a37